Thyroid Gland Disorders Treatment Market - Global Outlook and Forecast 2022-2028

January 2022 | 71 pages | ID: TCA35A6464A1EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Thyroid Gland Disorders Treatment in Global, including the following market information:

Global Thyroid Gland Disorders Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Thyroid Gland Disorders Treatment market was valued at 1815.2 million in 2021 and is projected to reach US$ 2059.2 million by 2028, at a CAGR of 1.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hypothyroidism Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Thyroid Gland Disorders Treatment include AbbVie, Merck KGaA, Lannett Company, Mylan, Allergan, Pfizer, Novartis, GlaxoSmithKline and Abbott Laboratories and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Thyroid Gland Disorders Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Thyroid Gland Disorders Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Thyroid Gland Disorders Treatment Market Segment Percentages, by Type, 2021 (%)

• Hypothyroidism
• Hyperthyroidism

Global Thyroid Gland Disorders Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Thyroid Gland Disorders Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Other

Global Thyroid Gland Disorders Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Thyroid Gland Disorders Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Thyroid Gland Disorders Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Thyroid Gland Disorders Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Merck KGaA
• Lannett Company
• Mylan
• Allergan
• Pfizer
• Novartis
• GlaxoSmithKline
• Abbott Laboratories
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Thyroid Gland Disorders Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Thyroid Gland Disorders Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL THYROID GLAND DISORDERS TREATMENT OVERALL MARKET SIZE

2.1 Global Thyroid Gland Disorders Treatment Market Size: 2021 VS 2028
2.2 Global Thyroid Gland Disorders Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Thyroid Gland Disorders Treatment Players in Global Market
3.2 Top Global Thyroid Gland Disorders Treatment Companies Ranked by Revenue
3.3 Global Thyroid Gland Disorders Treatment Revenue by Companies
3.4 Top 3 and Top 5 Thyroid Gland Disorders Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Thyroid Gland Disorders Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Thyroid Gland Disorders Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Thyroid Gland Disorders Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Thyroid Gland Disorders Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Thyroid Gland Disorders Treatment Market Size Markets, 2021 & 2028
  4.1.2 Hypothyroidism
  4.1.3 Hyperthyroidism
4.2 By Type - Global Thyroid Gland Disorders Treatment Revenue & Forecasts
  4.2.1 By Type - Global Thyroid Gland Disorders Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Thyroid Gland Disorders Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Thyroid Gland Disorders Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Thyroid Gland Disorders Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Other
5.2 By Application - Global Thyroid Gland Disorders Treatment Revenue & Forecasts
  5.2.1 By Application - Global Thyroid Gland Disorders Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Thyroid Gland Disorders Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Thyroid Gland Disorders Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Thyroid Gland Disorders Treatment Market Size, 2021 & 2028
6.2 By Region - Global Thyroid Gland Disorders Treatment Revenue & Forecasts
  6.2.1 By Region - Global Thyroid Gland Disorders Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Thyroid Gland Disorders Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Thyroid Gland Disorders Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Thyroid Gland Disorders Treatment Revenue, 2017-2028
  6.3.2 US Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.3.3 Canada Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.3.4 Mexico Thyroid Gland Disorders Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Thyroid Gland Disorders Treatment Revenue, 2017-2028
  6.4.2 Germany Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.4.3 France Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.4.4 U.K. Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.4.5 Italy Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.4.6 Russia Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.4.8 Benelux Thyroid Gland Disorders Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Thyroid Gland Disorders Treatment Revenue, 2017-2028
  6.5.2 China Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.5.3 Japan Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.5.4 South Korea Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.5.6 India Thyroid Gland Disorders Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Thyroid Gland Disorders Treatment Revenue, 2017-2028
  6.6.2 Brazil Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.6.3 Argentina Thyroid Gland Disorders Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Thyroid Gland Disorders Treatment Revenue, 2017-2028
  6.7.2 Turkey Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.7.3 Israel Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Thyroid Gland Disorders Treatment Market Size, 2017-2028
  6.7.5 UAE Thyroid Gland Disorders Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Thyroid Gland Disorders Treatment Major Product Offerings
  7.1.4 AbbVie Thyroid Gland Disorders Treatment Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Key News
7.2 Merck KGaA
  7.2.1 Merck KGaA Corporate Summary
  7.2.2 Merck KGaA Business Overview
  7.2.3 Merck KGaA Thyroid Gland Disorders Treatment Major Product Offerings
  7.2.4 Merck KGaA Thyroid Gland Disorders Treatment Revenue in Global Market (2017-2022)
  7.2.5 Merck KGaA Key News
7.3 Lannett Company
  7.3.1 Lannett Company Corporate Summary
  7.3.2 Lannett Company Business Overview
  7.3.3 Lannett Company Thyroid Gland Disorders Treatment Major Product Offerings
  7.3.4 Lannett Company Thyroid Gland Disorders Treatment Revenue in Global Market (2017-2022)
  7.3.5 Lannett Company Key News
7.4 Mylan
  7.4.1 Mylan Corporate Summary
  7.4.2 Mylan Business Overview
  7.4.3 Mylan Thyroid Gland Disorders Treatment Major Product Offerings
  7.4.4 Mylan Thyroid Gland Disorders Treatment Revenue in Global Market (2017-2022)
  7.4.5 Mylan Key News
7.5 Allergan
  7.5.1 Allergan Corporate Summary
  7.5.2 Allergan Business Overview
  7.5.3 Allergan Thyroid Gland Disorders Treatment Major Product Offerings
  7.5.4 Allergan Thyroid Gland Disorders Treatment Revenue in Global Market (2017-2022)
  7.5.5 Allergan Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Thyroid Gland Disorders Treatment Major Product Offerings
  7.6.4 Pfizer Thyroid Gland Disorders Treatment Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Key News
7.7 Novartis
  7.7.1 Novartis Corporate Summary
  7.7.2 Novartis Business Overview
  7.7.3 Novartis Thyroid Gland Disorders Treatment Major Product Offerings
  7.7.4 Novartis Thyroid Gland Disorders Treatment Revenue in Global Market (2017-2022)
  7.7.5 Novartis Key News
7.8 GlaxoSmithKline
  7.8.1 GlaxoSmithKline Corporate Summary
  7.8.2 GlaxoSmithKline Business Overview
  7.8.3 GlaxoSmithKline Thyroid Gland Disorders Treatment Major Product Offerings
  7.8.4 GlaxoSmithKline Thyroid Gland Disorders Treatment Revenue in Global Market (2017-2022)
  7.8.5 GlaxoSmithKline Key News
7.9 Abbott Laboratories
  7.9.1 Abbott Laboratories Corporate Summary
  7.9.2 Abbott Laboratories Business Overview
  7.9.3 Abbott Laboratories Thyroid Gland Disorders Treatment Major Product Offerings
  7.9.4 Abbott Laboratories Thyroid Gland Disorders Treatment Revenue in Global Market (2017-2022)
  7.9.5 Abbott Laboratories Key News
7.10 Sanofi
  7.10.1 Sanofi Corporate Summary
  7.10.2 Sanofi Business Overview
  7.10.3 Sanofi Thyroid Gland Disorders Treatment Major Product Offerings
  7.10.4 Sanofi Thyroid Gland Disorders Treatment Revenue in Global Market (2017-2022)
  7.10.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Thyroid Gland Disorders Treatment Market Opportunities & Trends in Global Market
Table 2. Thyroid Gland Disorders Treatment Market Drivers in Global Market
Table 3. Thyroid Gland Disorders Treatment Market Restraints in Global Market
Table 4. Key Players of Thyroid Gland Disorders Treatment in Global Market
Table 5. Top Thyroid Gland Disorders Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Thyroid Gland Disorders Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Thyroid Gland Disorders Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Thyroid Gland Disorders Treatment Product Type
Table 9. List of Global Tier 1 Thyroid Gland Disorders Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Thyroid Gland Disorders Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Thyroid Gland Disorders Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Thyroid Gland Disorders Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Thyroid Gland Disorders Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Thyroid Gland Disorders Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Thyroid Gland Disorders Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Thyroid Gland Disorders Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Thyroid Gland Disorders Treatment Product Offerings
Table 32. AbbVie Thyroid Gland Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Merck KGaA Corporate Summary
Table 34. Merck KGaA Thyroid Gland Disorders Treatment Product Offerings
Table 35. Merck KGaA Thyroid Gland Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Lannett Company Corporate Summary
Table 37. Lannett Company Thyroid Gland Disorders Treatment Product Offerings
Table 38. Lannett Company Thyroid Gland Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Mylan Corporate Summary
Table 40. Mylan Thyroid Gland Disorders Treatment Product Offerings
Table 41. Mylan Thyroid Gland Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Allergan Corporate Summary
Table 43. Allergan Thyroid Gland Disorders Treatment Product Offerings
Table 44. Allergan Thyroid Gland Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Thyroid Gland Disorders Treatment Product Offerings
Table 47. Pfizer Thyroid Gland Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Thyroid Gland Disorders Treatment Product Offerings
Table 50. Novartis Thyroid Gland Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 51. GlaxoSmithKline Corporate Summary
Table 52. GlaxoSmithKline Thyroid Gland Disorders Treatment Product Offerings
Table 53. GlaxoSmithKline Thyroid Gland Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Abbott Laboratories Corporate Summary
Table 55. Abbott Laboratories Thyroid Gland Disorders Treatment Product Offerings
Table 56. Abbott Laboratories Thyroid Gland Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Sanofi Corporate Summary
Table 58. Sanofi Thyroid Gland Disorders Treatment Product Offerings
Table 59. Sanofi Thyroid Gland Disorders Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Thyroid Gland Disorders Treatment Segment by Type in 2021
Figure 2. Thyroid Gland Disorders Treatment Segment by Application in 2021
Figure 3. Global Thyroid Gland Disorders Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Thyroid Gland Disorders Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Thyroid Gland Disorders Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Thyroid Gland Disorders Treatment Revenue in 2021
Figure 8. By Type - Global Thyroid Gland Disorders Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Thyroid Gland Disorders Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Thyroid Gland Disorders Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Thyroid Gland Disorders Treatment Revenue Market Share, 2017-2028
Figure 12. US Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Thyroid Gland Disorders Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Thyroid Gland Disorders Treatment Revenue Market Share, 2017-2028
Figure 24. China Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Thyroid Gland Disorders Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Thyroid Gland Disorders Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck KGaA Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Lannett Company Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mylan Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Allergan Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GlaxoSmithKline Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Abbott Laboratories Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sanofi Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)